Literature DB >> 15969667

Epicutaneous exposure to peanut protein prevents oral tolerance and enhances allergic sensitization.

J Strid1, J Hourihane, I Kimber, R Callard, S Strobel.   

Abstract

BACKGROUND: Food allergies are an important cause of life-threatening hypersensitivity reactions. Oral tolerance can be considered the default immune response to dietary antigens, with immune deviation resulting in allergic sensitization. However, primary sensitization to food allergens may not solely be through the gastrointestinal mucosa, as strong T-helper type 2 (Th2)-biased immunity can result from exposure to protein allergens on barrier-disrupted skin.
OBJECTIVE: The purpose of this study was to examine whether exposure to allergens through the skin may interfere with the normal development of oral tolerance and promote allergic sensitization to food proteins.
METHODS: Female BALB/c mice were exposed epicutaneously to peanut protein and induction of systemic oral tolerance through high dose feeds of peanut protein was subsequently assessed. Other mice were rendered tolerant prior to epicutaneous peanut exposure. Sensitivity to peanut was determined by assessing delayed-type hypersensitivity, proliferative, cytokine and antibody responses.
RESULTS: Epicutaneous exposure to peanut protein induced potent Th2-type immunity with high levels of IL-4 and serum IgE. Primary skin exposure prevented the subsequent induction of oral tolerance to peanut in an antigen-specific manner. Upon oral challenge, mice became further sensitized and developed strong peanut-specific IL-4 and IgE responses. Furthermore, animals with existing tolerance to peanut were partly sensitized following epicutaneous exposure.
CONCLUSION: Epicutaneous exposure to peanut protein can prevent induction of oral tolerance, and may even modify existing tolerance to peanut. Epidermal exposure to protein allergens selectively drives Th2-type responses, and as such may promote sensitization to food proteins upon gastrointestinal exposure.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15969667     DOI: 10.1111/j.1365-2222.2005.02260.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  51 in total

1.  An Animal Model for Wheat Allergy Skin Sensitisation: A Comparative Study in Naive versus Tolerant Brown Norway Rats.

Authors:  Anne-Sofie Ravn Ballegaard; Charlotte Bernhard Madsen; Katrine Lindholm Bøgh
Journal:  Int Arch Allergy Immunol       Date:  2018-12-05       Impact factor: 2.749

Review 2.  Future therapies for food allergies.

Authors:  Anna Nowak-Węgrzyn; Hugh A Sampson
Journal:  J Allergy Clin Immunol       Date:  2011-01-31       Impact factor: 10.793

3.  Epicutaneous immunization converts subsequent and established antigen-specific T helper type 1 (Th1) to Th2-type responses.

Authors:  Jessica Strid; Robin Callard; Stephan Strobel
Journal:  Immunology       Date:  2006-06-08       Impact factor: 7.397

Review 4.  New perspectives for use of native and engineered recombinant food proteins in treatment of food allergy.

Authors:  Anna Nowak-Wegrzyn
Journal:  Immunol Allergy Clin North Am       Date:  2007-02       Impact factor: 3.479

Review 5.  Early life factors that affect allergy development.

Authors:  Lisa A Reynolds; B Brett Finlay
Journal:  Nat Rev Immunol       Date:  2017-05-15       Impact factor: 53.106

Review 6.  Diagnosis, management, and investigational therapies for food allergies.

Authors:  Mike Kulis; Benjamin L Wright; Stacie M Jones; A Wesley Burks
Journal:  Gastroenterology       Date:  2015-01-26       Impact factor: 22.682

Review 7.  Food allergy: Insights into etiology, prevention, and treatment provided by murine models.

Authors:  Michiko K Oyoshi; Hans C Oettgen; Talal A Chatila; Raif S Geha; Paul J Bryce
Journal:  J Allergy Clin Immunol       Date:  2014-02       Impact factor: 10.793

Review 8.  Immunotherapy in food allergy.

Authors:  Toral Kamdar; Paul J Bryce
Journal:  Immunotherapy       Date:  2010-05       Impact factor: 4.196

Review 9.  Atopic dermatitis results in intrinsic barrier and immune abnormalities: implications for contact dermatitis.

Authors:  Julia K Gittler; James G Krueger; Emma Guttman-Yassky
Journal:  J Allergy Clin Immunol       Date:  2012-08-28       Impact factor: 10.793

10.  Type B CpG oligodeoxynucleotides induce Th1 responses to peanut antigens: modulation of sensitization and utility in a truncated immunotherapy regimen in mice.

Authors:  Mike Kulis; Balachandra Gorentla; A Wesley Burks; Xiao-Ping Zhong
Journal:  Mol Nutr Food Res       Date:  2013-02-05       Impact factor: 5.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.